Trial Profile
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumour volumes in recurrent glioblastoma patients treated with bevacizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Glioblastoma
- Focus Pharmacodynamics
- 10 Nov 2015 New trial record